中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析

陈伟伟 黄坤 刘锐 刘承利

陈伟伟, 黄坤, 刘锐, 刘承利. 经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析[J]. 临床肝胆病杂志, 2019, 35(3): 559-564. DOI: 10.3969/j.issn.1001-5256.2019.03.021.
引用本文: 陈伟伟, 黄坤, 刘锐, 刘承利. 经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析[J]. 临床肝胆病杂志, 2019, 35(3): 559-564. DOI: 10.3969/j.issn.1001-5256.2019.03.021.
Chen WeiWei, Huang Kun, Liu Rui, Liu ChengLi. Clinical effect of percutaneous transhepatic cholangial drainage combined with biliary stent implantation in treatment of high malignant obstructive jaundice and the influencing factors for prognosis[J]. J Clin Hepatol, 2019, 35(3): 559-564. DOI: 10.3969/j.issn.1001-5256.2019.03.021.
Citation: Chen WeiWei, Huang Kun, Liu Rui, Liu ChengLi. Clinical effect of percutaneous transhepatic cholangial drainage combined with biliary stent implantation in treatment of high malignant obstructive jaundice and the influencing factors for prognosis[J]. J Clin Hepatol, 2019, 35(3): 559-564. DOI: 10.3969/j.issn.1001-5256.2019.03.021.

经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析

DOI: 10.3969/j.issn.1001-5256.2019.03.021
基金项目: 

首都市民健康项目培育课题(Z131100006813010); 

详细信息
  • 中图分类号: R730.5

Clinical effect of percutaneous transhepatic cholangial drainage combined with biliary stent implantation in treatment of high malignant obstructive jaundice and the influencing factors for prognosis

Research funding: 

 

  • 摘要:

    目的探讨经皮肝穿刺胆管引流术(PTCD)联合胆道支架植入术治疗高位恶性梗阻性黄疸(MOJ)的效果及影响生存期的危险因素。方法回顾性分析解放军空军总医院肝胆外科2015年6月-2017年6月收治的92例高位MOJ患者临床资料。符合正态分布的计量资料两组间比较采用t检验,多组间比较采用方差分析,进一步两两比较采用SNK-q检验;非正态分布的计量资料两组间比较采用Mann-Whitney U检验。计数资料组间比较采用χ2检验。采用受试者工作特征曲线(ROC曲线)明确影响生存期指标的最佳截断值,根据最佳截断值进行分组,采用Kaplan-Meier法进行生存分析。多因素Cox风险模型分析明确影响患者生存期的独立危险因素。结果所有患者均获得随访,随访时间1~10个月,中位随访时间6个月。随访期间56例患者死亡,36例患者存活,中位生存期(OS)为6个月,随访末期生存率39. 1%,半年生存率44. 6%。14例患者出现术后并发症,并发症发生率为15. 2%。术后3 d及术后1周的TBil、DBil、ALT、AST复查结果显示,上述指标水平显著下降且差异均有统计学意义(F值分别为206. 264、1...

     

  • [1] XU XJ, LI JJ, WU J, et al. A systematic review and meta-a-nalysis of intraluminal brachytherapy versus stent alone in thetreatment of malignant obstructive jaundice[J]. Cardiovasc In-ter Radiol, 2018, 41 (2) :206-217.
    [2] MA J, LUO J, GU J, et al. Malignant obstructive jaundicetreated with intraluminal placement of Iodine-125 seedstrands and metal stents:An analysis of long-term outcomesand prognostic features[J]. Brachytherapy, 2018, 17 (4) :689-695.
    [3] WANG L, YU WF. Obstructive jaundice and perioperative man-agement[J]. Acta Anaesthesiol Taiwan, 2014, 52 (1) :22-29.
    [4] XU G. Clinical effect of biliary metal stent implantation via en-doscopic retrograde cholangiopancreatography in treatment ofunresectable malignant extrahepatic biliary obstruction[J]. JClin Hepatol, 2018, 34 (2) :337-340. (in Chinese) 徐刚.经内镜逆行胰胆管造影胆道金属支架置入治疗不可切除肝外胆道恶性梗阻的效果观察[J].临床肝胆病杂志, 2018, 34 (2) :337-340.
    [5] CHEN Y, WANG XL, YAN ZP, et al. The use of125I seed strands forintraluminal brachytherapy of malignant obstructive jaundice[J].Cancer Biother Radiopharm, 2012, 27 (5) :317-323.
    [6] YAO GL, JIANG Y, ZHAO YX, et al. Comparative efficacy ofpalliative biliary enteric extraction and percutaneous biliarystenting under ultrasound guidance in the treatment of malig-nant obstructive jaundice[J]. J Clin Exp Med, 2018, 22 (17) :2430-2433. (in Chinese) 姚广力, 江怡, 赵云歆, 等.恶性梗阻性黄疸患者经皮经肝胆管引流途径胆道支架置入与姑息性胆肠内引流的疗效比较[J].临床和实验医学杂志, 2018, 22 (17) :2430-2433.
    [7] CHEN TS, LI SY. Percutaneous transhepatic cholangial drain-age for the comprehensive treatment of malignant biliary ob-struction[J]. Clin J Med Offic, 2017, 45 (9) :881-883. (inChinese) 陈挺松, 李淑英.恶性胆道梗阻经皮肝穿综合治疗[J].临床军医杂志, 2017, 45 (9) :881-883.
    [8] KIKUYAMA M, SHIRANE N, KAWAGUCHI S, et al. New 14-mm diameter Niti-S biliary uncovered metal stent for unresect-able distal biliary malignant obstruction[J]. World J Gastroint-est Endosc, 2018, 10 (1) :16-22.
    [9] WANG X, LI XC. Rsearch advances in palliative treatment ofcholangiocarcinoma[J]. J Clin Hepatol, 2016, 32 (5) :1022-1025. (in Chinese) 王荇, 李相成.胆管癌姑息治疗的研究进展[J].临床肝胆病杂志, 2016, 32 (5) :1022-1025.
    [10] XU C, SHI HB, LIU S, et al. Transhepatic biliary drainage forthe treatment of low position malignant obstructive jaundice:An analysis of related factors influencing the prognosis[J]. JVasc Interv Radiol, 2013, 125 (3) :360-367.
    [11] CHANG ZK, KOU ZP, LI SX, et al. To evaluate the correlationbetween the change of immune system function before and af-ter the treatment of malignant obstructive type jaundice treatedwith biliary stent[J]. Eur Rev Med Pharmaco, 2018, 22 (6) :1638.
    [12] TANG K, SUI LL, XU G, et al. Effects of different palliativejaundice reducing methods on immunologic functions in pa-tients with advanced malignant obstructive jaundice[J]. Anti-cancer Res, 2017, 37 (8) :4665-4670.
    [13] ADANG S, RINO AG, MURDANI A, et al. Changes in tumornekrosis factor alpha and interleukin 6 levels in patients withobstructive jaundice due to pancreatobiliary cancer who under-went biliary drainage[J]. Tijoghade, 2016, 17 (2) :92-98.
    [14] WANG WJ, YU CH. Improvement in liver function in patientswith malignant obstructive jaundice after endoscopic biliarymetallic stent drainage[J]. J Clin Hepatol, 2015, 31 (8) :1295-1298. (in Chinese) 王文君, 于聪慧.胆道支架引流术对恶性梗阻性黄疸患者肝功能的影响[J].临床肝胆病杂志, 2015, 31 (8) :1295-1298.
    [15] ZHANG C, YANG YL, WU P, et al. Prevention and treatmentof complications for full-covered self-expanding removablemetal stents in malignant obstructive jaundice[J]. Natl Med JChina, 2015, 95 (6) :416-419. (in Chinese) 张诚, 杨玉龙, 吴萍, 等.全覆膜自膨式可回收金属支架治疗恶性梗阻性黄疸的并发症及防治策略[J].中华医学杂志, 2015, 95 (6) :416-419.
    [16] DELDEN OMV, LAMERIS JS. Percutaneous drainage and stent-ing for palliation of malignant bile duct obstruction[J]. Eur Radi-ol, 2008, 18 (3) :448-456.
    [17] INAL M, AKGL E, AKSUNGUR E, et al. Percutaneous self-expandable uncovered metallic stents in malignant biliary ob-struction:Complications, follow-up and reintervention in 154patients[J]. Acta Radiol, 2015, 44 (2) :139-146.
    [18] ZHANG GY, LI WT, PENG WJ, et al. Clinical outcomes andprediction of survival following percutaneous biliary drainagefor malignant obstructive jaundice[J]. Oncol Lett, 2014, 7 (4) :1185-1190.
    [19] HYUN H, CHOI SY, KIM KA, et al. Safety and efficacy of per-cutaneous biliary covered stent placement in patients with ma-lignant biliary hilar obstruction; correlation with liver function[J]. Cardiovasc Intervent Radiol, 2016, 39 (9) :1298-1305.
  • 加载中
计量
  • 文章访问数:  1976
  • HTML全文浏览量:  53
  • PDF下载量:  326
  • 被引次数: 0
出版历程
  • 出版日期:  2019-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回